Scarica l'app Stockscreener
2.28
1.72%
-0.04
Precedente Chiudi:
$2.32
Aprire:
$2.33
Volume 24 ore:
260.25K
Relative Volume:
0.82
Capitalizzazione di mercato:
$193.18M
Reddito:
$25.14M
Utile/perdita netta:
$-21.57M
Rapporto P/E:
-8.4444
EPS:
-0.27
Flusso di cassa netto:
$-12.23M
1 W Prestazione:
-2.56%
1M Prestazione:
-4.60%
6M Prestazione:
+25.27%
1 anno Prestazione:
+30.29%
Intervallo 1D:
$2.21
$2.38
Intervallo di 1 settimana:
$2.21
$2.49
Portata 52W:
$1.66
$3.29
Stereotaxis Inc Stock (STXS) Company Profile
Nome
Stereotaxis Inc
Settore
Industria
Telefono
314-678-6100
Indirizzo
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Confronta STXS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.28 | 193.18M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
521.96 | 185.91B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
226.87 | 65.59B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.89 | 41.99B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
228.69 | 33.57B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
327.56 | 23.72B | 2.88B | 499.60M | 321.60M | 6.74 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-01-10 | Iniziato | ROTH MKM | Buy |
| 2022-07-12 | Iniziato | Aegis Capital | Buy |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2022-01-05 | Iniziato | Craig Hallum | Buy |
| 2022-01-05 | Iniziato | Loop Capital | Buy |
| 2021-05-26 | Iniziato | Piper Sandler | Overweight |
| 2020-09-08 | Iniziato | Northland Capital | Outperform |
| 2020-04-09 | Iniziato | Cowen | Outperform |
| 2020-04-07 | Iniziato | Lake Street | Buy |
Mostra tutto
Stereotaxis Inc Borsa (STXS) Ultime notizie
Charles Schwab Investment Management Inc. Boosts Stock Position in Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World
STXS Stock Up Post NMPA Nod for Cardiovascular Care With Magbot - MSN
Stereotaxis (STXS) Stock Surges Amid Positive Ratings in Medical Device Sector - GuruFocus.com
Stereotaxis (NYSEAMERICAN:STXS) Shares Down 2.2%Here's What Happened - MarketBeat
Items Tagged with 'endovascular robotics' - BioWorld Online
Items Tagged with 'atrioventricular nodal reentrant tachycardia' - BioWorld Online
China clears Stereotaxis/Microport’s robotic ablation catheter - BioWorld Online
NMPA approves Stereotaxis and MicroPort’s ablation catheter - Yahoo Finance
Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA - GlobeNewswire
Stereotaxis Secures Crucial NMPA Approval for Revolutionary Magnetic Ablation Catheter in China - StockTitan
Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems - GlobeNewswire
Stereotaxis? GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems - Marketscreener.com
Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025 - Seeking Alpha
Stereotaxis surgical robot gets regulatory nod in China - Robot Report
Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
Pre-Market Momentum For Stereotaxis (STXS) Following Key Approval - Stocks Telegraph
Stereotaxis’ Genesis Surgical Robot OK’ed in China - MPO-mag
Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China - GlobeNewswire
Stereotaxis Secures China NMPA Approval for Genesis Robotic Surgery System - StockTitan
Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System - GlobeNewswire
Stereotaxis Genesis Robotic System Debuts at Portugal's Leading Cardiac Center | STXS Stock News - StockTitan
FY2024 EPS Estimates for Stereotaxis Reduced by Roth Capital - MarketBeat
Stereotaxis Inc (STXS) Quarterly 10-Q Report - Quartzy
STXS Stock Drops 5% Despite Strong Buy Ratings from Analysts - GuruFocus.com
Stereotaxis Reports Strong Q3 Growth in Robotics - Yahoo Finance
Stereotaxis Inc. (STXS) Reports Q3 Loss, Tops Revenue Estimates - MSN
Stereotaxis, Inc. (AMEX:STXS) Q3 2024 Earnings Call Transcript - Insider Monkey
Stereotaxis Reports 2024 Third Quarter Financial Results - The Manila Times
Stereotaxis earnings missed by $0.03, revenue topped estimates - Investing.com UK
Stereotaxis Q3 Revenue Surges 18% as GenesisX Robotic System Gains CE Mark | STXS Stock News - StockTitan
Kansas hospital begins robotic heart program with Stereotaxis surgical robot - Robot Report
Robotic Catheter Systems Market Expected to See Prominent - openPR
Stereotaxis Inc (STXS) Q3 2024: Everything You Need To Know Ahea - GuruFocus.com
Kansas health centre adopts Stereotaxis’ endovascular robot - Medical Device Network
University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology - GlobeNewswire
Stereotaxis Genesis Robot System Launches at Kansas Health, Marks Major Expansion | STXS Stock News - StockTitan
Global Medical Robot Market to Reach USD 38701.5 Million by 2034 at a 12.9% of CAGR, Driven by Break - PharmiWeb.com
Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024 - GlobeNewswire
STXSStereotaxis, Inc. Latest Stock News & Market Updates - StockTitan
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation - GlobeNewswire
Congenital Heart Defect Devices Market Advancements Highlighted by Report 2024: Size, Growth, Key Players, ... - WhaTech
Electrophysiology Catheters Market 2024: Growth Drivers, Technological Innovations, and Competitive Landscape - WhaTech
Stereotaxis Q1 2024 Earnings Preview - MSN
Stereotaxis Inc Azioni (STXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):